Table 2.
Type-specific anal HPV prevalence, overall and by age (n=606).
| 9v vaccine HPV type | Overall prevalence |
Age (years) |
||||
|---|---|---|---|---|---|---|
| % (n) | 35–44 n=195 % (n) |
45–54 n=229 % (n) |
55–64 n=123 % (n) |
65+ n=59 % (n) |
P trend | |
| HPV16 | 29.4 (178) | 28.2 (55) | 30.6 (70) | 33.3 (41) | 20.3 (12) | 0.74 |
| HPV18 | 12.2 (74) | 18.5 (36) | 10.9 (25) | 8.1 (10) | 5.1 (3) | 0.001 |
| HPV31 | 5.9 (36) | 5.1 (10) | 7.0 (16) | 4.9 (6) | 6.8 (4) | 0.82 |
| HPV33 | 5.1 (31) | 5.1 (10) | 6.1 (14) | 4.9 (6) | 1.7 (1) | 0.40 |
| HPV45 | 13.9 (84) | 15.9 (31) | 14.0 (32) | 11.4 (14) | 11.9 (7) | 0.25 |
| HPV52 | 13.5 (82) | 15.4 (30) | 13.5 (31) | 12.2 (15) | 10.2 (6) | 0.25 |
| HPV58 | 11.1 (67) | 11.3 (22) | 10.5 (24) | 12.2 (15) | 10.2 (6) | 0.99 |
| HPV6 | 18.0 (109) | 22.1 (43) | 17.9 (41) | 13.8 (17) | 13.6 (8) | 0.04 |
| HPV11 | 9.6 (58) | 13.3 (26) | 8.7 (20) | 8.1 (10) | 3.4 (2) | 0.02 |